Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | +50.00% | -.--% | -.--% |
2023 | Motion for Asset Sale Approved for OncoSec Medical Incorporated | CI |
2023 | Motion for Asset Sale Filed by OncoSec Medical Incorporated | CI |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 28.35M |
---|---|---|---|---|---|
Net income 2021 | -45M | Net income 2022 | -34M | EV / Sales 2021 | - |
Net cash position 2021 | 33.63M | Net cash position 2022 | 1.12M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.59
x | P/E ratio 2022 |
-0.83
x | Employees | 41 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.57% |
1 day | +50.00% | ||
1 month | +200.00% | ||
3 months | +200.00% | ||
6 months | +200.00% |
Managers | Title | Age | Since |
---|---|---|---|
David Canton
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Sandra Aung
PRN | Corporate Officer/Principal | - | 20-10-11 |
Bridget O'Keeffe
PRN | Corporate Officer/Principal | - | 21-02-17 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.79K | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- ONCSQ Stock